PubRank

Willibald Hochholzer

Author PubWeight™ 44.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009 8.05
2 Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011 3.72
3 Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 2008 3.10
4 High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation 2012 2.94
5 Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA 2011 2.57
6 N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction. Am J Med 2011 1.75
7 Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009 1.71
8 Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J 2011 1.58
9 QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure. Heart 2007 1.55
10 Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur Heart J 2011 1.31
11 Long-term outcomes of routine versus provisional T-stenting for de novo coronary bifurcation lesions: five-year results of the Bifurcations Bad Krozingen I study. EuroIntervention 2015 1.08
12 Diagnostic and prognostic impact of copeptin and high-sensitivity cardiac troponin T in patients with pre-existing coronary artery disease and suspected acute myocardial infarction. Heart 2012 1.06
13 Paraoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placement. Circ Cardiovasc Genet 2011 1.03
14 Markers of plaque instability in the early diagnosis and risk stratification of acute myocardial infarction. Clin Chem 2011 0.94
15 Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study. J Am Coll Cardiol 2006 0.93
16 Genetics of platelet inhibitor treatment. Br J Clin Pharmacol 2014 0.89
17 The impact of platelet count on mortality in unstable angina/non-ST-segment elevation myocardial infarction. Am Heart J 2006 0.89
18 Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med 2012 0.87
19 Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Thromb Haemost 2008 0.85
20 Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study. Platelets 2012 0.84
21 Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient data. Thromb Haemost 2015 0.83
22 Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department. Int J Cardiol 2007 0.81
23 Diabetes mellitus, CYP2C19 genotype, and response to escalating doses of clopidogrel. Insights from the ELEVATE-TIMI 56 Trial. Thromb Haemost 2016 0.80
24 [The new 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation]. Dtsch Med Wochenschr 2016 0.79
25 Impact of reticulated platelets on antiplatelet response to thienopyridines is independent of platelet turnover. Thromb Haemost 2016 0.79
26 Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients. Thromb Haemost 2013 0.78
27 Novel biomarkers in cardiovascular disease: research tools or ready for personalized medicine? Cardiol Rev 2012 0.77
28 Response to letters regarding article, "High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease". Circulation 2013 0.77
29 Antiplatelet response to the 150-mg maintenance dose of clopidogrel in patients with insufficient platelet inhibition after clopidogrel loading for elective coronary stent placement. EuroIntervention 2008 0.75
30 On-clopidogrel platelet reactivity: a target in sight? J Am Coll Cardiol 2011 0.75
31 Influence of smoking on treatment with clopidogrel. JAMA 2012 0.75
32 On-clopidogrel platelet reactivity as predictor for long-term clinical outcome in patients after planned discontinuation of clopidogrel. Thromb Haemost 2017 0.75
33 Predictors of high-sensitivity cardiac troponin in stable patients undergoing coronary angiography. EuroIntervention 2016 0.75
34 Pseudoephedrine inhibits T-cell activation by targeting NF-κB, NFAT and AP-1 signaling pathways. Immunopharmacol Immunotoxicol 2011 0.75
35 Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia. Int J Cardiol 2006 0.75
36 Impact of body temperature on in-hospital and long-term mortality in patients with acute heart failure. Swiss Med Wkly 2008 0.75
37 Temporal variability in the antiplatelet effects of clopidogrel and aspirin after elective drug-eluting stent implantation. An ADAPT-DES substudy. Thromb Haemost 2015 0.75
38 [Long term ECG findings. Acute soccer fever]. MMW Fortschr Med 2012 0.75
39 Reply: Platelet Reactivity: Journey to the End of the Night. J Am Coll Cardiol 2017 0.75
40 The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. Int J Cardiol 2008 0.75
41 How safe is the outpatient management of patients with acute chest pain and mildly increased cardiac troponin concentrations? Clin Chem 2012 0.75